ENTITY
Takeda Pharmaceutical

Takeda Pharmaceutical (4502 JP)

220
Analysis
Health CareJapan
Takeda Pharmaceutical Co Ltd focuses on the Research & Development, Manufacturing, Sales and Marketing and Import/Export of Pharmaceutical Drugs. The Company focuses on the following core therapeutic areas: Cardiovascular & Metabolic, Oncology, Central Nervous System, Respiratory & Immunology, General Medicine (Gastrointestinal & Genitourinary) and Vaccine.
more
Refresh
09 May 2018 21:19

Takeda/Shire I : On Drug Deals and Deckchairs

What was rumored, approached, rejected, re-offered and rejected twice more, then agreed.... is now official. Takeda Pharmaceutical Co Ltd (4502 JP)...

Logo
564 Views
Share
08 May 2018 19:56

Takeda Acquires Shire for US$64 Billion – We Continue Our Support of the Deal

Takeda Pharmaceutical Co Ltd (4502 JP) acquiring Shire PLC (SHP LN) is the biggest overseas acquisition ever by a Japanese drugmaker – we continue...

29 Apr 2018 20:57

Japan Sector Weights : 3 Month Incremental Change - Domestic Sectors ▲ Global Sectors ▼

TOPIX SECTOR CLASSIFICATIONS ARE 50 YEARS OLD - The TOPIX 17 and TOPIX 33 Sectors that most analysts use to monitor sectoral performance were first...

Logo
151 Views
Share
bullishShire PLC
27 Apr 2018 09:18

Maintaining Our FVE for Shire and Takeda During Extended Offer Period

We’re not making any changes to our fair value estimates for Shire PLC (SHP LN) (GBP 48.90 per share/$205 per ADR) or Takeda Pharmaceutical Co Ltd...

Logo
124 Views
Share
25 Apr 2018 23:54

No Deal Is a Big Deal for Takeda

Takeda Pharmaceutical Co Ltd (4502 JP)'s revised April 24, 2018 proposal of £49 / share (~$206 / ADS), values Shire PLC (SHP LN) at ~$64b, its...

x